0001958244-23-002830.txt : 20231215 0001958244-23-002830.hdr.sgml : 20231215 20231215172426 ACCESSION NUMBER: 0001958244-23-002830 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: 4D Molecular Therapeutics, Inc. CENTRAL INDEX KEY: 0001650648 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473506994 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39782 FILM NUMBER: 231491442 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5105052680 MAIL ADDRESS: STREET 1: 5858 HORTON STREET #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: 4D Molecular Therapeutics Inc. DATE OF NAME CHANGE: 20200506 FORMER COMPANY: FORMER CONFORMED NAME: 4D Molecular Therapeutics Inc DATE OF NAME CHANGE: 20150811 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Kirn David CENTRAL INDEX KEY: 0001834021 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O 4D MOLECULAR THERAPEUTICS INC. STREET 2: 5858 HORTON STREET #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 144 1 primary_doc.xml 144 0001834021 XXXXXXXX LIVE 0001650648 4D Molecular Therapeutics, Inc. 001-39782 5858 Horton Street Suite 455 Emeryville CA 94608 1-510-505-2680 David Kirn Officer Class A Common Shares Goldman Sachs & Co. LLC 200 West Street New York NY 10282 28632 508504.32 42753607 12/15/2023 NASD Class A Common Shares 12/15/2020 Founder's Shares Issuer N 28632 12/15/2020 None Y The sales of shares set forth herein are made in connection with a selling plan dated 8/17/2023 that is intended to comply with Rule 10b5-1(c). 12/15/2023 08/17/2023 Goldman Sachs & Co. LLC on behalf of David Kirn